Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk

Clinical Epigenetics(2020)10.1186/s13148-019-0801-3Source: DataRank Database

Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk is a research paper published in Clinical Epigenetics (2020). On theSindex it has a DataRank of 2.7. It has been cited 81 times, with 68 citing works in its 1-hop citation network.

N/A

2.7DataRank · unranked

Scored on demand from live citation data

Open Access81 citations · 68 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (35 grants)OA: goldTopics (47)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 25%Citation Network 75%

Base Score Contribution

0.661

From this paper's citation signal

Citation Network Contribution

2.0

From 53 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 68 citers.

Development and validation of a five-immune gene prognostic risk model in colon cancer
BMC Cancer202087 citations32 referencesContributes 0.140
The Development of Three‐DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer
BioMed Research International20209 citations22 referencesContributes 0.105
Riskscore Model Based on Oxidative Stress–Related Genes May Facilitate the Prognosis Evaluation for Patients With Colon Cancer
Clinical and Translational Gastroenterology20237 citations22 referencesContributes 0.095
Accelerated biological aging in COVID-19 patients
Nature Communications2022225 citations68 referencesContributes 0.080
Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon
Cancer Research202247 citations51 referencesContributes 0.076

Authors (15)

Sean K. Maden ORCID,E. Georg Luebeck ORCID,Christopher I. Li ORCID,Polly A. Newcomb ORCID,Cornelia M. Ulrich ORCID

Live enrichment

PubMed:31900199 PMC:PMC6942339

National Institutes of Health

Grant: P30CA15704

National Institutes of Health

Grant: R01CA194663

National Institutes of Health

Grant: RO1CA220004

National Institutes of Health

Grant: RO1CA189184

National Institutes of Health

Grant: R01CA207371

National Institutes of Health

Grant: U01CA206110

National Institutes of Health

Grant: U54CA143862

National Institutes of Health

Grant: P01CA077852

National Institutes of Health

Grant: U01152756

National Cancer Institute

Grant: R01CA189184

National Cancer Institute

Grant: P30CA042014

National Cancer Institute

Grant: R50CA233042

NCI NIH HHS

Grant: P30 CA015704

NCI NIH HHS

Grant: R01 CA220004

NCI NIH HHS

Grant: U01 CA152756

National Institutes of Health

Grant: 3P30CA015704-42S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3P30CA042014-23S1

Protocol Review and Monitoring System

National Institutes of Health

Grant: 3P30CA042014-30S2

Cancer Center Support Grant

National Institutes of Health

Grant: 1R01CA194663-01

(PQC1) Accelerated biological aging and colon polyp to cancer progression

National Institutes of Health

Grant: 5U01CA206110-07

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study

National Institutes of Health

Grant: 5R01CA207371-03

Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence

National Institutes of Health

Grant: 5U54CA143862-04

A Center for the Convergence of Physical Science and Cancer Biology

National Institutes of Health

Grant: 5R50CA233042-04

Translational Epigenomics in Gastrointestinal Cancer

National Institutes of Health

Grant: 5R50CA233042-09

Translational Science of Gastrointestinal Cancer Initiation and Progression

National Institutes of Health

Grant: 5U01CA206110-04

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study

National Institutes of Health

Grant: 5R01CA189184-04

Discovery and verification of novel biomarkers of colorectal cancer recurrence

National Institutes of Health

Grant: 2P01CA077852-16A1

Bioinformatics/statistical support

National Institutes of Health

Grant: 1R01CA220004-01

(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.

Fred Hutchinson Cancer Research Center

Cottrell Family Fund

Huntsman Cancer Foundation

Listwin Family Foundation

R.A.C.E. Charities

Seattle Translational Tumor Research program

Rodger Haggitt Endowed Chair

goldLicense: cc-by

publisherhttps://clinicalepigeneticsjournal.biomedcentral.com/counter/pdf/10.1186/s13148-019-0801-3

publisherhttp://link.springer.com/content/pdf/10.1186/s13148-019-0801-3.pdf

publisherhttp://link.springer.com/article/10.1186/s13148-019-0801-3/fulltext.html

repositoryhttps://researchmgt.monash.edu/ws/files/311758289/311757023_oa.pdf

repositoryhttp://hdl.handle.net/11343/247311

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

ColonMucous MembraneHumansAdenomaColonic NeoplasmsGenetic Predisposition to DiseaseLinear ModelsRisk FactorsDNA MethylationEpigenesis, GeneticAgingAdultAgedAged, 80 and overMiddle AgedFemaleMaleEpigenomicsBiomarkers

Keywords

DNA methylationColorectal CancerEpigenetic ClockEpigenetic Age AccelerationBiological/epigenetic AgeAdenomaAdultEpigenomicsMaleAgingColon610Epigenesis, GeneticRisk FactorsHumansGenetic Predisposition to DiseaseAgedAged, 80 and overMucous MembraneResearchMiddle AgedColonic NeoplasmsLinear ModelsFemaleBiomarkers

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health

MOESM1 of Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk

10.6084/m9.figshare.11507985.v1figshare

MOESM1 of Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk

10.6084/m9.figshare.11507985figshare

Additional file 1 of Development and validation of a five-immune gene prognostic risk model in colon cancer

10.6084/m9.figshare.12262538.v1figshare

Additional file 1 of Development and validation of a five-immune gene prognostic risk model in colon cancer

10.6084/m9.figshare.12262538figshare

Additional file 2 of Development and validation of a five-immune gene prognostic risk model in colon cancer

10.6084/m9.figshare.12262541.v1figshare